PTH Compounds for Diverse Industrial Applications

Publication ID: 24-11857603_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “PTH Compounds for Diverse Industrial Applications,” Published Technical Disclosure No. 24-11857603_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857603_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,603.

Summary of the Inventive Concept

The present inventive concept discloses novel applications of PTH compounds, originally designed for hypoparathyroidism treatment, in entirely new fields, including environmental pollutant monitoring, agricultural crop yield optimization, biomarker detection, neurological disorder treatment, and food quality control.

Background and Problem Solved

The original patent, 'PTH compounds with low peak-to-trough ratios,' provided a breakthrough in treating hypoparathyroidism. However, its potential extends beyond the pharmaceutical realm. The inventive concept addresses the limitations of the original patent by exploring new industries and use cases, where the unique pharmacokinetic profile of PTH compounds can be leveraged to create innovative solutions.

Detailed Description of the Inventive Concept

The new claims describe systems and methods that utilize PTH compounds in various industrial settings. For instance, Claim 1 proposes a system for monitoring environmental pollutants, where the PTH compound's peak-to-trough ratio enables accurate and efficient pollutant detection in water samples. Similarly, Claim 2 outlines a method for optimizing agricultural crop yields by administering the PTH compound to the soil, allowing for tailored irrigation cycles. Claims 3-5 detail devices and methods for detecting biomarkers in bodily fluids, treating neurological disorders, and monitoring food quality, respectively, all leveraging the PTH compound's unique properties.

Novelty and Inventive Step

The inventive concept introduces a paradigm shift in the application of PTH compounds, moving beyond pharmaceutical uses to tackle diverse industrial challenges. The novelty lies in the unexpected adaptation of the PTH compound's pharmacokinetic profile to address problems in environmental monitoring, agriculture, biomarker detection, neurological disorders, and food quality control.

Alternative Embodiments and Variations

Other potential embodiments of the inventive concept could include using PTH compounds in industrial process control, materials science, or even energy storage. Variations of the systems and methods described in the new claims could involve different administration routes, sampling intervals, or detection mechanisms, ensuring broad coverage of the inventive concept.

Potential Commercial Applications and Market

The inventive concept has far-reaching commercial potential, targeting industries such as environmental monitoring, agriculture, healthcare, and food safety. The market for these applications is substantial, with growing demands for innovative solutions to pressing problems. The PTH compound-based systems and methods have the potential to disrupt existing markets and create new opportunities for businesses and entrepreneurs.

CPC Classifications

SectionClassGroup
A A61 A61K38/29
A A61 A61K9/00
A A61 A61K47/34
A A61 A61K47/60

Field of Art

Pharmaceutical biotechnology with a focus on peptide-based therapeutic compounds, specifically parathyroid hormone (PTH) delivery systems and pharmacokinetic optimization

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in pharmaceutical sciences or bioengineering, expertise in peptide drug design, pharmacokinetic modeling, and interdisciplinary application of biological compounds

Obviousness Rationale

A PHOSITA would recognize that the unique pharmacokinetic profile of the PTH compound with a low peak-to-trough ratio represents a versatile technological platform that could be systematically adapted across multiple technical domains. The source patent's fundamental innovation of precise compound delivery enables predictable extensions into diverse sensing, monitoring, and intervention applications. The consistent sub-4 peak-to-trough ratio provides a transferable technological characteristic that a skilled practitioner would naturally explore for alternative uses beyond the original pharmaceutical context.

Obvious Combinations & Variations

Source Patent Element
Subcutaneous administration of PTH compound with controlled pharmacokinetic profile
PTD Variation
Environmental pollutant monitoring system using identical PTH compound delivery mechanism
Obviousness Reasoning
Known technique of adapting pharmaceutical delivery mechanisms to sensing technologies, with predictable results in measurement precision
Source Patent Element
Precise administration interval for pharmaceutical treatment
PTD Variation
Agricultural crop yield optimization method using identical pharmacokinetic interval control
Obviousness Reasoning
Predictable extension of controlled release principles into agricultural biotechnology applications
Source Patent Element
Pharmacokinetic profile with consistent peak-to-trough ratio
PTD Variation
Biomarker detection device leveraging compound's stable release characteristics
Obviousness Reasoning
Finite identified solution for creating consistent measurement intervals using known compound properties
Source Patent Element
Subcutaneous drug delivery targeting specific physiological condition
PTD Variation
Neurological disorder treatment method applying identical delivery mechanism
Obviousness Reasoning
Known technique of translating drug delivery principles across related medical domains
Source Patent Element
Controlled pharmaceutical compound with precise pharmacodynamic profile
PTD Variation
Food quality monitoring system utilizing compound's consistent release characteristics
Obviousness Reasoning
Predictable application of pharmaceutical compound properties to quality control technologies
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in the Published Technical Disclosure (PTD) would have been obvious to a Person Having Ordinary Skill In The Art at the time of invention, given the teachings of US Patent 11857603. The PTD demonstrates that the source patent's fundamental innovation of a PTH compound with a low peak-to-trough ratio represents a generalizable technological platform with predictable extensions across multiple technical domains, thereby rendering subsequent claims involving similar pharmacokinetic applications prima facie obvious.

Original Patent Information

Patent NumberUS 11,857,603
TitlePTH compounds with low peak-to-trough ratios
Assignee(s)ASCENDIS PHARMA BONE DISEASES A/S